2020 Volume 15 Issue 3 Pages 227-231
Glucocorticoids are one of the key drugs used in palliative therapy. They have several palliative effects. However, aside from these effects, glucocorticoids have anti-tumor effects on lymphoid malignancies. In particular, for patients with lymphoid malignancy in the terminal stage of the disease, this medical modality can produce both symptomatic relief and anti-tumor effects without serious side effects. This article presents two impressive cases of patients with terminal lymphoid malignancy treated with glucocorticoids, who showed survival advantages and improved quality of life.